Nonalcoholic fatty liver disease: Diagnosis and relation to metabolic syndrome and approach to treatment

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Current Diabetes Reports

• Publication date

  2008-02-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/S11892-008-0006-1PMID 18366995
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Telmisartan, An Angiotensin II Type 1 Receptor Blocker, Controls Progress of Nonalcoholic Steatohepatitis in Rats

  2007cited by this paper
• Nonalcoholic Fatty Liver Disease in Severely Obese Subjects

  2007cited by this paper
• The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD

  2007cited by this paper
• Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis

  2007cited by this paper
• Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences.

  2007cited by this paper
• Effects of nonalcoholic fatty liver disease on the development of metabolic disorders

  2007cited by this paper
• Pediatric nonalcoholic fatty liver disease (NAFLD): a "growing" problem?

  2007cited by this paper
• The rosiglitazone story--lessons from an FDA Advisory Committee meeting.

  2007cited by this paper
• Prevalence of Nonalcoholic Fatty Liver Disease and Its Association With Cardiovascular Disease Among Type 2 Diabetic Patients

  2007cited by this paper
• Regulation of nuclear translocation of HDAC3 by IkappaBalpha is required for tumor necrosis factor inhibition of peroxisome proliferator-activated receptor gamma function.

  2006cited by this paper
• Utility of a new model to diagnose an alcohol basis for steatohepatitis.

  2006cited by this paper
• The Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver Disease

  2006cited by this paper
• Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease

  2006cited by this paper
• Hepatic histology in obese patients undergoing bariatric surgery.

  2006influential reference
• Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.

  2006cited by this paper
• A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis.

  2006cited by this paper
• The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis.

  2006cited by this paper
• The evolution of severe steatosis after bariatric surgery is related to insulin resistance.

  2006cited by this paper
• Regulation of Nuclear Translocation of HDAC3 by IκBα Is Required for Tumor Necrosis Factor Inhibition of Peroxisome Proliferator-activated Receptor γ Function*

  2006cited by this paper
• Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C

  2006cited by this paper
• Long‐term follow‐up of patients with NAFLD and elevated liver enzymes

  2006cited by this paper
• Weight Loss and Non-alcoholic Fatty Liver Disease: Falls In Gamma-Glutamyl Transferase Concentrations are Associated with Histologic Improvement

  2006cited by this paper
• Liver fibrosis.

  2005cited by this paper
• The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies.

  2005cited by this paper
• Erratum: Liver fibrosis (Journal of Clinical Investigation (2005) 115 (209-218) DOI:10.1172/JCI200524282)

  2005cited by this paper
• Design and validation of a histological scoring system for nonalcoholic fatty liver disease

  2005cited by this paper
• Sampling variability of liver biopsy in nonalcoholic fatty liver disease.

  2005cited by this paper
• STEATOSIS IN CHRONIC HEPATITIS C: WHY DOES IT REALLY MATTER?

  2005cited by this paper
• A Randomized Controlled Trial of Metformin versus Vitamin E or Prescriptive Diet in Nonalcoholic Fatty Liver Disease

  2005cited by this paper
• Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice.

  2005cited by this paper
• Adipokines in NASH: Postprandial lipid metabolism as a link between adiponectin and liver disease

  2005cited by this paper
• Molecular mediators of hepatic steatosis and liver injury.

  2004cited by this paper
• Angiotensin Type 1 Receptor Blockers Induce Peroxisome Proliferator–Activated Receptor-γ Activity

  2004cited by this paper
• Non‐alcoholic steatohepatitis in type 2 diabetes mellitus

  2004cited by this paper
• Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity

  2004cited by this paper
• Metformin in the treatment of patients with non‐alcoholic steatohepatitis

  2004cited by this paper
• A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis

  2004cited by this paper
• Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized trial

  2004cited by this paper
• Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis

  2004cited by this paper
• Beyond insulin resistance in NASH: TNF‐α or adiponectin?

  2004cited by this paper
• A pilot study of orlistat treatment in obese, non‐alcoholic steatohepatitis patients

  2004cited by this paper
• Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR‐γ ligand rosiglitazone

  2003cited by this paper
• Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis

  2003cited by this paper
• Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States.

  2003influential reference
• Is weight reduction an effective therapy for nonalcoholic fatty liver? A systematic review.

  2003cited by this paper
• Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values

  2003cited by this paper
• The prevalence and etiology of elevated aminotransferase levels in the United States

  2003influential reference
• Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis

  2003cited by this paper
• Expression and localization of AT1 receptors in hepatic Kupffer cells: its potential role in regulating a fibrogenic response.

  2003cited by this paper
• Insulin signaling in the transcriptional and posttranscriptional regulation of CYP2E1 expression

  2002cited by this paper
• The utility of radiological imaging in nonalcoholic fatty liver disease.

  2002cited by this paper
• Drugs and Steatohepatitis

  2002cited by this paper
• NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

  2002cited by this paper
• Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases.

  2002cited by this paper
• Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology.

  2001influential reference
• Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities.

  2001cited by this paper
• Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease

  2001cited by this paper
• An assessment of the role of liver biopsies in asymptomatic patients with chronic liver test abnormalities.

  2000influential reference
• An assessment of the role of liver biopsies in asymptomatic patients with chronic liver test abnormalities

  2000cited by this paper
• Quantitative estimation of attenuation in ultrasound video images: correlation with histology in diffuse liver disease.

  2000cited by this paper
• Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy

  2000cited by this paper
• Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis

  1999cited by this paper
• Double-Blind Randomized Placebo-Controlled Trial of Orlistat or the Treatment of Nonalcoholic Fatty Liver Disease

  year unknowncited by this paper

• Lipid and phospholipid composition of the inner mitochondrial membrane of hepatocytes under conditions of glutamate-induced steatohepatosis and correction with nanocrystalline cerium dioxide

  2025cites this paper
• A case-control regression analysis of liver enzymes in obesity-induced metabolic disorders in South Asian females

  2024cites this paper
• Coffee consumption and cardiometabolic health: a comprehensive review of the evidence

  2024cites this paper
• The relationship between leptin-to-adiponectin ratio and HOMA-IR and metabolic syndrome in five African-origin populations

  2024cites this paper
• Regulatory Mechanisms in Biosystems

  2023cites this paper
• Evaluating Carotid intima media thickness (CIMT) of patients with Non - Alcoholic fatty liver disease (NAFLD) as a risk factor for atherosclerosis and correlation with metabolic syndrome

  2021cites this paper
• Prediction of new onset of diabetes mellitus during a 10-year period by using a combination of levels of alanine aminotransferase and γ-glutamyl transferase.

  2021cites this paper
• Circulating total bilirubin and risk of non-alcoholic fatty liver disease in the PREVEND study: observational findings and a Mendelian randomization study

  2019cites this paper
• Dullaart, R. P. F. (2019). Circulating total bilirubin and risk of non-alcoholic fatty liver disease in the PREVEND study: observational findings and a Mendelian randomization

  2019cites this paper
• Increased Risk for Cardiovascular Events in Patients with Diabetic Kidney Disease and Non-Alcoholic Fatty Liver Disease

  2018cites this paper
• Green tea extract attenuates non alcoholic fatty liver disease by decreasing hyperlipidemia and enhancing Superoxide dismutase activity in cholesterol-fed rats

  2018cites this paper
• PFP alleviates nonalcoholic steatohepatitis fatty liver in both Apo E-/- mice and Changliver cell[S].

  2017cites this paper
• Long-term change in incidence and risk factors of cirrhosis and hepatocellular carcinoma in Crete, Greece: a 25-year study

  2017cites this paper
• Associations of the fatty liver and hepatic steatosis indices with risk of cardiovascular disease: Interrelationship with age.

  2017cites this paper
• Gamma‐glutamyltransferase—friend or foe within?

  2016cites this paper
• Effect of fruit vinegars on liver damage and oxidative stress in high-fat-fed rats

  2016cites this paper
• Protective effects of aerobic swimming training on high-fat diet induced nonalcoholic fatty liver disease: regulation of lipid metabolism via PANDER-AKT pathway.

  2015cites this paper
• Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.

  2014cites this paper
• Alanine Aminotransferase and Risk of the Metabolic Syndrome: A Linear Dose-Response Relationship

  2014cites this paper
• Non-alcoholic fatty liver disease in obese children and the relationship between metabolic syndrome criteria.

  2014cites this paper
• Liver aminotransferases and risk of incident type 2 diabetes: a systematic review and meta-analysis.

  2013cites this paper
• Systematic Reviews and Meta- and Pooled Analyses Liver Aminotransferases and Risk of Incident Type 2 Diabetes: A Systematic Review and Meta-Analysis

  2013cites this paper
• Biochemical Evaluation of Some Liver Enzymes in Type 2 Diabetes Mellitus Iraqi Patients

  2012cites this paper
• Swimming training beneficial effects in a mice model of nonalcoholic fatty liver disease.

  2012cites this paper
• Association of Alanine Aminotransferase Levels (ALT) with the Hepatic Insulin Resistance Index (HIRI): a cross-sectional study

  2012cites this paper
• Non-alcoholic fatty liver disease: An early mediator predicting metabolic syndrome in obese children?

  2011cites this paper
• Centrizonal Arteries and Microvessels in Nonalcoholic Steatohepatitis

  2011cites this paper
• Suboptimal maternal nutrition, during early fetal liver development, promotes lipid accumulation in the liver of obese offspring

  2011influential citation
• Fatty liver and lipotoxicity.

  2010cites this paper
• Positive correlations of liver enzymes with metabolic syndrome including insulin resistance in newly diagnosed type 2 diabetes mellitus

  2010cites this paper
• Epidemiological Investigation of Metabolic Syndrome and Analysis of Relevant Factors in North-Eastern China

  2010cites this paper
• Rosiglitazone Aggravates Nonalcoholic Fatty Pancreatic Disease in C57BL/6 Mice Fed High-Fat and High-Sucrose Diet

  2009cites this paper
• Epidemiological investigation of metabolic syndrome and analysis of relevant factors in northeast China

  2009cites this paper
• Non alcoholic fatty liver disease and metabolic syndrome.

  2009cites this paper
• Freqüência e fatores de risco da Doença Hepática Gordurosa Não Alcoólica em pacientes com Diabetes Mellitus tipo 2 atendidos no HC-UFPE

  2008cites this paper